Paw BLOCH | Cited by 545 | of Novo Nordisk, Copenhagen | Read 1 publication | Contact Paw BLOCH

2015年9月11日 · Semantic Scholar profile for Paw Bloch, with 31 highly influential citations and 4 scientific research papers.

2015年9月24日 · Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analogue that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity. …

Protracted GLP-1 compounds and therapeutic uses thereof. KNUDSEN LOTTE B ET AL: "Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily...

Senior lab. technician at Novo Nordisk · Novo Nordisk · Region Sjælland · 100 forbindelser på LinkedIn. Se Paw Blochs profil på LinkedIn, et fagligt forum med 1 milliard medlemmer.

To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple molecules separated by whitespace or by comma. Search specific patents by importing a CSV or list of …

ABSTRACT: Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analogue that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity. …

Paw Bloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United …

2007年12月28日 · [Translated] The present invention relates to a semi-recombinant method for the production of GLP-1 analogs and derivatives containing non-proteinogenic amino acids in …

Protracted GLP-1 compounds and therapeutic uses thereof.